Skip to main content
. Author manuscript; available in PMC: 2011 Mar 16.
Published in final edited form as: Cancer Chemother Pharmacol. 2010 May 4;67(2):393–400. doi: 10.1007/s00280-010-1331-z

Table 3.

Final Parameter Estimates and 95% Confidence Intervals from NONMEM

Parameter Estimate Relative SE (%)
Cl (L/h) 25.0 5.96
In subjects receiving only one cycle 17.0 14.6*
V1 (L) 5.68 12.4
Cl2 (L/h) 99.6 15.0
V2 (L) (female) 19.0 11.6
V2 (L) (male) 34.8 15.5*
Cl3 (L/h) 8.76 10.8
V3 (L) 40.4 19.0
Variability in Cl (%CV) 34.8 25.1
Variability in V1 (%CV) 60.6 38.4
Variability in V2 (%CV) 41.5 28.7
RUV (%CV) 17.5 18.3
RUV (SD) 0.0168 35.4

Cl, total body clearance; V apparent volume of distribution; CV, coefficient of variation; RUV residual unexplained variability; relative SE, measure of precision computed by dividing the standard error (SE) by the value of the estimate × 100.

*

Relative SE expressed in terms of the multiplicative term, for the covariate